ANALYSIS OF HIV-1 CELL ENTRY USING CHEMICALLY INDUCED T CELL MUTANTS
ANALYSIS OF HIV-1 CELL ENTRY USING CHEMICALLY INDUCED T CELL MUTANTS
批准号:
3811244
负责人:
H GOLDING
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
我们先前已经描述了EMS诱导的CEM突变体的分离,
表达中等水平的表面CD 4(野生型的50- 75
表达),但与野生型CEM细胞以及与
其他具有类似CD 4表达的突变体对HIV 1的易感性
感染这些突变体产生的合胞体数量减少,
用gp 160-牛痘载体(VSC 25)感染。此外,传染性
使用HIV 1(MN株)的检测显示,
感染性,通过病毒滴定、长期RT测定和
定量PCR(感染后72小时)。其中两个变种人
对PKC激活剂TPA的诱导反应异常。类似于
在野生型CEM中,它们在感染后1小时内将其表面CD 4下调50%。
TPA治疗。相比之下,TPA处理24小时诱导了
CD 4和CD 25(IL 2 R)在亲本系以及其他突变体,但不是
这两个变种人TPA诱导的膜受体的磷酸化是
发现CD 4和CD 5正常,但CD 7不正常。使用的CAT测定
HIV 1 LTR(139)-CAT质粒+ TPA诱导完全阴性,
这两个变种人
用对照质粒转染,Actin-CAT和RSV-CAT导致
CAT活动有趣的是,用LTR-CAT + pCV 1(达特)共转染,
不导致CAT基因通过TAR元件的反式激活。凝胶
使用NF-k结合寡核苷酸和核提取物的阻滞试验
TPA和TNF诱导的细胞,显示出NF-k结合蛋白的诱导,
突变体,但在一个显着的,降低的水平。进一步的生化
对这些突变体的分析将允许鉴定细胞基因,
这对最佳的HIV I感染率很重要,
PKC磷酸化途径。
英文摘要
We have previously described the isolation of EMS-induced CEM mutants which
express intermediate levels of surface CD4 (50-75% of wild type
expression), yet differ markedly from wild type CEM cells as well as from
other mutants with similar CD4 expression in their susceptibility to HIV 1
infection. These mutants produced reduced number of syncytia following
infection with the gpl6O-vaccinia vector (VSC25). Furthermore,,infectivity
assays using HIV 1 (MN strain), showed a significant reduction in their
infectibility, as judged by virus titrations, longterm RT assays, and
quantitative PCR (ar 72 hr post infection). Two of these mutants were found
to respond abnormally to induction with the PKC activator TPA. Similar to
wild type CEM, they down regulated their surface CD4 by 50% within 1 hr of
TPA treatment. In contrast, TPA treatment for 24 hr. induces expression of
CD4 and CD25 (IL2R) on the parental line as well as other mutants, but not
on these two mutants. TPA induced phosphorylation of membrane receptors was
found to be normal for CD4 and CD5, but not for CD7. CAT assays using the
HIV 1 LTR (139)-CAT plasmid + TPA induction were completely negative for
these two mutants.
Transfection with control plasmids, e.g., Actin-CAT and RSV-CAT resulted in
CAT activity. Interestingly, cotransfection with LTR-CAT + pCV1 (tat) did
not result in transactivation of the CAT gene via the TAR element. Gel
retardation assay using the NF-k binding oligo and nuclear extracts from
TPA and TNF-induced cells, showed induction of NF-k binding protein in the
mutants, but at a significantly ,reduced levels. Further biochemical
analyses of these mutants would allow identification of cellular gene(s)
which are important for optimal HIV I infection land are dependent on the
PKC phosphorylation pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRODUCTION OF ANTI-HIV-1 THERAPEUTIC VACCINE
-
批准号:5200713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
EVALUATION OF SAFETY OF MONOCLONAL ANTIBODIES AGAINST HIV ENVELOPE AND ITS CELLUL
-
批准号:6293720
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV1 INFECTION AS TARGETS FOR ANTIVIRAL THERAPY
-
批准号:6161239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 MEDIATED MEMBRANE FUSION AS TARGET OF ANTI-VIRAL THERAPY
-
批准号:2568922
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
GENERATION OF AUTOANTIBODIES IN HIV-1 VACCINE GROUPS
-
批准号:3770316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR THERAPY
-
批准号:3770315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF ANTI-HIV-1 VACCINE
-
批准号:3748147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CHARACTERIZATION OF T CELL RECEPTOR GENES IN ALLOREACTIVE CLONES
-
批准号:3939366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:
PRODUCTION OF T-INDEPENDENT HIV 1 VACCINE
-
批准号:3811246
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
STUDIES OF HIV-1 ENV-MEDIATED MEMBRANE FUSION AND SYNCYTIA FORMATION
-
批准号:3804800
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF PEPTIDE-BASED, T CELL INDEPENDENT HIV-1 VACCINE
-
批准号:3804795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of vaccinia IgG (VIG) in the protection of mi
-
批准号:6545148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Cellular genes as targets for anti-HIV Therapies
-
批准号:6545092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 mediated membrane fusion as target for anti-viral
-
批准号:6678831
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF ANTI-HIV-1 THERAPEUTIC VACCINE
-
批准号:2568923
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR THERAPY
-
批准号:3748144
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR ANTI-VIRAL THERAPY
-
批准号:5200710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
STUDIES OF HIV-1 ENV-MEDIATED MEMBRANE FUSION AND SYNCYTIA FORMATION
-
批准号:3792527
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
EVALUATION OF NEW CARRIERS AND ADJUVANTS FOR HIV-1 VACCINES.
-
批准号:6293722
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 mediated membrane fusion as target for anti-viral therapy
-
批准号:6433505
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
海外基金